The Iowa orthopaedic journal · 2025
Patient Reported Outcomes for Maisonneuve Fractures using PROMIS Physical Function Scores.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Wheelwright John C, Thorne Tyler, Haller Justin M
Аннотация
BACKGROUND: Limited research exits surrounding Maisonneuve fractures due to rarity. Additionally, even less data has been published evaluating the patient reported outcomes of surgically treated Maisonneuve fractures using the Patient-Reported Outcomes Measurement Information System (PROMIS) Physical Function (PF) and Pain Intensity (PI) score. The aim of this study was to put forth a cohort of patient reported outcomes using PROMIS PF and PROMIS PI.
METHODS: Maisonneuve fracture patients with minimum 12-month follow-up treated at a level-1 trauma center from 2006 to 2020 completed PROMIS PF and PROMIS PI tests. Medical records were reviewed to gather patient characteristics, mechanism of energy, operative variables, and complications.
RESULTS: The final cohort consisted of 28 patients with a mean follow up of 59.6 months with a mean time between injury and primary operation of 7.9 days. The mean PROMIS PF and PROMIS PI scores of the cohort were 56.3 (SD 10.8 [95% CI 15.9, 171.0] and 40.9 (SD 7.5 [95% CI 36,44]) respectively. The mean Foot and Ankle Ability Measure (FAAM) Activities of Daily Living (ADL) and FAAM Sports were 90.4 (15.4 [95% CI 84, 109] and 75.2 (SD 28.9 [95% CI 62, 91] respectively. Thirteen patients received syndesmotic screws only, nine received plate + syndesmotic screw, three received suture-button devices only, and three patients received syndesmotic screws + suture-button device. When the methods of syndesmotic fixation were divided into three groups, (1- syndesmotic screws only, 2-plate + syndesmotic screw, 3- suture-button device only and syndesmotic screw + suture-button device), the PROMIS PF scores for each treatment group was 60.2 (SD 8.5 [95% CI 54, 66]], 46.5 (SD 9.7 [95% CI 41, 53]), 62.8 (SD 9.7 [95% CI 54, 77]), respectively. The treatment group of plate + syndesmotic screw has significantly worse PROMIS PF compared to the syndesmotic screw only group.
CONCLUSION: This study is the largest cohort utilizing PROMIS PF and PI to evaluate surgically treated Maisonneuve fractures. The resultant PROMIS PF an PI scores further demonstrate the favorable outcomes for surgical treatment of Maisonneuve fractures. Level of Evidence: III.
METHODS: Maisonneuve fracture patients with minimum 12-month follow-up treated at a level-1 trauma center from 2006 to 2020 completed PROMIS PF and PROMIS PI tests. Medical records were reviewed to gather patient characteristics, mechanism of energy, operative variables, and complications.
RESULTS: The final cohort consisted of 28 patients with a mean follow up of 59.6 months with a mean time between injury and primary operation of 7.9 days. The mean PROMIS PF and PROMIS PI scores of the cohort were 56.3 (SD 10.8 [95% CI 15.9, 171.0] and 40.9 (SD 7.5 [95% CI 36,44]) respectively. The mean Foot and Ankle Ability Measure (FAAM) Activities of Daily Living (ADL) and FAAM Sports were 90.4 (15.4 [95% CI 84, 109] and 75.2 (SD 28.9 [95% CI 62, 91] respectively. Thirteen patients received syndesmotic screws only, nine received plate + syndesmotic screw, three received suture-button devices only, and three patients received syndesmotic screws + suture-button device. When the methods of syndesmotic fixation were divided into three groups, (1- syndesmotic screws only, 2-plate + syndesmotic screw, 3- suture-button device only and syndesmotic screw + suture-button device), the PROMIS PF scores for each treatment group was 60.2 (SD 8.5 [95% CI 54, 66]], 46.5 (SD 9.7 [95% CI 41, 53]), 62.8 (SD 9.7 [95% CI 54, 77]), respectively. The treatment group of plate + syndesmotic screw has significantly worse PROMIS PF compared to the syndesmotic screw only group.
CONCLUSION: This study is the largest cohort utilizing PROMIS PF and PI to evaluate surgically treated Maisonneuve fractures. The resultant PROMIS PF an PI scores further demonstrate the favorable outcomes for surgical treatment of Maisonneuve fractures. Level of Evidence: III.